>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:
  • SPWH +12.3%, ADSK +12%, MCK +8.7%, DE +7%, SB +6.8%, GPS +4.4%, ROST +3.8%, CRM +2.5%, AMAT +2%, HCC +0.9%
M&A news:
  • DYN +20.5% (Vistra Energy (VST) is in talks to purchase DYN, according to WSJ)
  • PXLW +2% (Pixelworks to acquire ViXS in an all-stock transaction consisting of ~3.7 million shares of Pixelworks common stock valued at ~$20.2 million)
Select Brazil related names bouncing in pre-mkt following yesterday's declines:
  • BSBR +5.4%, PBR +4.1%, VALE +3.9%, GOL +3.7%, BBD +2.1%, GGB +1.9%
Select metals/mining stocks trading higher:
  • HMY +4%, AU +3.5%, GFI +3.2%, MT +1.4%, RIO +1.2%, BHP +1%
Other news:
  • GLYC +8.2% (seeing continued strength in after hours - being attributed to positive Suntrust comments)
  • FBIO +5.8% (receives NOA from the USPTO for an application describes and claims a dosing regimen of intravenous (IV) 50 mg tramadol)
  • SNGX +5% (indicated higher after Randal J. Kirk - in joint filing with Third Security/Intrexon- disclosed slightly increased active stake to 7.9%)
  • CNHI +4.9% (in sympathy with DE)
  • GBT +4.5% (announces new data supporting its GBT440 program in sickle cell disease will be presented at the upcoming 22nd Congress of the European Hematology Association)
  • FOLD +3.6% (on track to report top-line data from the ESSENCE study during)
  • SYF +1.9% (Synchrony Financial plans to increase quarterly common stock dividend to $0.15 per share and approval of a $1.64 billion share repurchase program through June 30, 2018)
  • CAT +1.8% (in sympathy with DE)
  • SHOP +1.8% (prices offering of 5.5 mln shares of Class A subordinate voting shares at $91.00 per share)
  • BABA +1.5% (slightly rebounding after yesterday's declines)
  • EGLT +1% (presents data from a harm reduction model at the 36th American Pain Society annual meeting)
  • DAR +0.9% (CFO disclosed purchase of 19710 shares worth nearly $300K)
Analyst comments:
  • ARNA +16.5% (initiated with a Outperform at Leerink Partners; tgt $5 )
  • PRTK +12.1% (initiated with Strong Buy at Raymond James; tgt $36)
  • VTL +9.6% ( initiated with Outperform at Raymond James; tgt $6)
  • LL +5.7% (upgraded to Outperform from Perform at Oppenheimer)
  • AXSM +5.5% (initiated with a Buy at BTIG Research; tgt $14 )
  • PANW +3.6% upgraded to Buy from Hold at Jefferies)
  • NVDA +2.4% (initiated with Outperform at Bernstein)
  • TMUS +1.8% (added to Conviction Buy List at Goldman)
  • WMT +0.5% (upgraded to Market Perform from Underperform at BMO Capital Markets)